BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16792828)

  • 1. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
    J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent? How do primary care professionals prepare women for cervical smears: a qualitative study.
    Chew-Graham C; Mole E; Evans LJ; Rogers A
    Patient Educ Couns; 2006 Jun; 61(3):381-8. PubMed ID: 15964735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of self-reported Pap smear history in Norwegian women.
    Klungsøyr O; Nygård M; Skare G; Eriksen T; Nygård JF
    J Med Screen; 2009; 16(2):91-7. PubMed ID: 19564522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An audit of a cervical smear screening programme.
    Moodie PJ; Kljakovic M; McLeod DK
    N Z Med J; 1989 Jul; 102(872):374-6. PubMed ID: 2797554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement between patient self-reports and medical records for Pap smear histories.
    McKenna MT; Speers M; Mallin K; Warnecke R
    Am J Prev Med; 1992; 8(5):287-91. PubMed ID: 1419128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fallacy of the screening interval for cervical smears.
    Boyce JG; Fruchter RG; Romanzi L; Sillman FH; Maiman M
    Obstet Gynecol; 1990 Oct; 76(4):627-32. PubMed ID: 2216192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical screening in women over the age of 50: results of a population-based multicentre study.
    Flannelly G; Monaghan J; Cruickshank M; Duncan I; Johnson J; Jordan J; Campbell M; Patnick J
    BJOG; 2004 Apr; 111(4):362-8. PubMed ID: 15008774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
    Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
    Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening history of women in Malmö with invasive cervical cancer.
    Lindqvist PG; Hellsten C; Rippe A
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical screening in general practice: call and recall.
    Ridsdale LL
    J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
    Lynge E; Poll P
    IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the women overdue for a smear test in a general practice cervical screening programme.
    Meadows P
    J R Coll Gen Pract; 1987 Nov; 37(304):500-3. PubMed ID: 3505643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.